Transcript Programma Scientifico

SCIENTIFIC
PROGRAMME
HIV and COINFECTIONS
3rd ICONA FOUNDATION MEETING
ROME
January 26-27, 2017
Auditorium Via Veneto
Scientific Coordinators
Andrea Antinori
Antonella Castagna
Francesca Ceccherini-Silberstein
Alessandro Cozzi-Lepri
Antonella d’Arminio Monforte
Enrico Girardi
Sergio Lo Caputo
Italian
Cohort
Cristina Mussini
I.
C
O.
Massimo Puoti
N
A.
Naive
Antiretrovirals
Fondazione Icona
ITALIAN COHORT NAIVE ANTIRETROVIRALS
Conceived by Professor Mauro Moroni
I.
C
N
O.
A.
HEPA
Hepatitis Icona Cohort
FACULTY
Massimo Andreoni
Giovanni Guaraldi
University of Tor Vergata, Rome
Gioacchino Angarano
University Hospital of Modena and Reggio Emilia,
Modena
University Hospital of Bari
Maria Rosaria Iardino
Andrea Antinori
NPS Italia Onlus, Milan
IRCCS INMI Lazzaro Spallanzani, Rome
Giuseppe Ippolito
Stefania Carrara
IRCCS INMI Lazzaro Spallanzani, Rome
IRCCS INMI Lazzaro Spallanzani,
Rome
Antonella Castagna
Adriano Lazzarin
San Raffaele Hospital, Milan
San Raffaele Hospital, Milan
Francesco Castelli
Sergio Lo Caputo
University of Brescia
University Hospital of Bari
Roberto Cauda
Patrizia Lorenzini
Catholic University, Rome
IRCCS INMI Lazzaro Spallanzani, Rome
Francesca Ceccherini-Silberstein
Franco Maggiolo
University of Tor Vergata, Rome
ASST Papa Giovanni XXIII, Bergamo
Antonella Cingolani
Giulia Marchetti
Catholic University, Rome
Alessandro Cozzi-Lepri
Royal Free & University College Medical School,
University College of London UK
Davide Croce
Carlo Cattaneo University LIUC, Castellanza VA
Antonella d’Arminio Monforte
ASST S. Paolo and Carlo, San Paolo Hospital,
University of Milan
Andrea De Luca
ASST S. Paolo and Carlo, San Paolo Hospital,
University of Milan
Simone Marcotullio
NADIR Onlus, Rome
Cristina Mussini
University Hospital of Modena and Reggio Emilia,
Modena
Carlo Federico Perno
University of Tor Vergata, Rome
Massimo Puoti
University Hospital of Siena
Niguarda Ca’ Granda Hospital, Milan
Antonio Di Biagio
Giuliano Rizzardini
IRCCS AOU San Martino-IST, Genoa
Giovanni Di Perri
University of Turin
Iuri Fanti
Catholic University, Rome
Ida Fortino
AIFA Agenzia Italiana del Farmaco, Milan
Massimo Galli
ASST Fatebenefratelli Sacco, Luigi Sacco Hospital,
University of Milan
Ivan Gardini
EpaC Onlus, Vimercate MB
Enrico Girardi
ASST Fatebenefratelli Sacco, Luigi Sacco Hospital,
University of Milan
Stefano Rusconi
ASST Fatebenefratelli Sacco, Luigi Sacco Hospital,
University of Milan
Annalisa Saracino
University Hospital of Bari
Milensu Shanyinde
Royal Free & University College Medical School,
University College of London UK
Gloria Taliani
Sapienza University, Rome
Alessandro Tavelli
IRCCS INMI Lazzaro Spallanzani, Rome
ASST S. Paolo and Carlo, San Paolo Hospital,
University of Milan
Andrea Gori
Mauro Zaccarelli
San Gerardo Hospital, University of Milano-Bicocca, Monza
IRCCS INMI Lazzaro Spallanzani, Rome
HIV and COINFECTIONS
3rd ICONA FOUNDATION MEETING
10.00-11.00
Registration
Thursday, January 26, 2017
11.00-11.15
Introduction: rationale and aims of the third ICONA Meeting
A. Antinori, A. d’Arminio Monforte, M. Puoti
11.15-13.15
Round Table
Chairs: A. Antinori, C.F. Perno
Coinfection HIV-HCV: a public health problem and available
resources
Participants: D. Croce, A. d’Arminio Monforte, I. Fortino (TBC), I. Gardini,
E. Girardi, M.R. Iardino, S. Marcotullio (TBC), M. Puoti, G. Rizzardini
13.15-14.00 Lunch
14.00-15.00
Main Lectures
Chairs: F. Castelli, G. Di Perri
14.00-14.30
14.30-15.00
Analyzing current trends of HIV epidemic:
the role of cohort studies E. Girardi
HIV therapy: what’s new? M. Andreoni
SCIENTIFIC
PROGRAMME
15.00-19.00
ICONA and HepaICONA research in HIV and HIV-HCV coinfection
Session 1 Chairs: M. Galli, A. Lazzarin
15.00-15.15
ART use and risk of ALT elevation in HIV/HCV co-infected patients
M. Shanyinde
15.15-15.30
Multiple lines of antiretroviral therapy in relation to HCV co-infections
G. Marchetti
15.30-15.45
15.45-16.00
16.00-16.15
Durability and tolerability of first-line combination including RAL
or ATV/r or DRV/r P. Lorenzini
Prescription pattern and determinants of Dolutegravir use
in naïve HIV-infected patients S. Lo Caputo
Survival in HIV+ patients with lymphoma compared to general population
A. Cingolani
16.15-16.30
16.30-16.45
Impact of social determinants on ART A. Saracino
Discussion
16.45-17.00 Coffee break
Session 2 Chairs: G. Angarano, F. Ceccherini-Silberstein
17.00-17.15
Reducing Pill Burden vs. Drug Burden as Strategy of ART Simplification
M. Zaccarelli
17.15-17.30
CD4/CD8 Ratio in Patients switching Triple vs Dual/Mono Therapy
C. Mussini
17.30-17.45
Use of a score for prediction of biological-age in HIV+ individuals
G. Guaraldi
17.45-18.00
HIV-positive subjects treated with the STR cobicistat, elvitegravir,
emtricitabine and tenofovir when ART-naïve in clinical practice
A. Cozzi-Lepri
18.00-18.15
Discussion
18.15-19.00
Final considerations A. Antinori, A. d’Arminio Monforte, M. Puoti
SCIENTIFIC
PROGRAMME
Friday, January 27, 2017
08.30-09.30
Chairs: R. Cauda, G. Ippolito
ICONA and HepaICONA research projects
09.30-11.30
Parallel Workshops on data from ICONA and HepaICONA reports
09.30-10.30
Workshop 1 Epidemiology A. Cingolani, E. Girardi, A. Saracino
Workshop 2 Coinfections A. De Luca, M. Puoti, G. Taliani
10.30-11.30
Workshop 3 HIV Therapy A. Di Biagio, F. Maggiolo, S. Rusconi
Workshop 4 HIV Comorbidities A. Gori, G. Guaraldi, G. Marchetti
11.30-12.30
Wrap-up from parallel Workshops
Chairs: A. Castagna, C. Mussini
12.15-12.30
Workshop 1 Epidemiology A. Cingolani, E. Girardi, A. Saracino
Workshop 2 Coinfections A. De Luca, M. Puoti, G. Taliani
Workshop 3 HIV Therapy A. Di Biagio, F. Maggiolo, S. Rusconi
Workshop 4 HIV Comorbidities A. Gori, G. Guaraldi, G. Marchetti
12.30-13.50
Open discussion among ICONA and HepaICONA Centres
11.30-11.45
11.45-12.00
12.00-12.15
Facilitators: S. Carrara, I. Fanti, A. Tavelli
13.50-14.00
Final considerations A. Antinori, A. d’Arminio Monforte, M. Puoti
14.00
Lunch
ROME January 26-27, 2017 Auditorium Via Veneto
HIV and COINFECTIONS
3rd ICONA FOUNDATION MEETING
ROME
January 26-27, 2017
Auditorium Via Veneto
Venue
Auditorium Via Veneto
Via Veneto, 89 - 00187 Rome I
www.auditoriumviaveneto.it
Crediti ECM
La Commissione Nazionale per la Formazione Continua in Medicina ha assegnato n. 11 crediti formativi al
Meeting (N. ECM 150-175350), per Biologi, Farmacisti ospedalieri e territoriali e Medici Specialisti in Malattie
Infettive, Microbiologia e Virologia, Igiene, Epidemiologia e Sanità Pubblica, Direzione Medica di Presidio Ospedaliero,
Allergologia e Immunologia Clinica, Medicina Interna e Gastroenterologia. L’assegnazione dei crediti formativi è subordinata alla presenza al 100% dei lavori e alla corretta compilazione di almeno il 75% delle domande proposte
all’interno del questionario di valutazione finale. È inoltre obbligatoria la rilevazione delle presenze e la compilazione
del questionario di valutazione e di gradimento dell’evento formativo.
CME Provider and Organizing Secretariat
Italian
Cohort
Effetti Srl
Via Gallarate, 106 - 20151 Milan, Italy
Phone +39 02 3343281 - Fax +39 02 38002105
Mail: [email protected]
www.effetti.it - www.fondazioneicona.org
I.
C
N
O.
A.
Naive
Antiretrovirals
Fondazione Icona
ITALIAN COHORT NAIVE ANTIRETROVIRALS
Conceived by Professor Mauro Moroni
I.
C
N
O.
A.
HEPA
Hepatitis Icona Cohort